SrasV1, Main, Exploration, bibRecord, 000877

Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version.

Identifieur interne : 000877 ( Main/Exploration ); précédent : 000876; suivant : 000878

Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version.

Auteurs : Luis Pino [Colombie] ; Carlos Perez [Colombie] ; Andres Cardona [Colombie] ; Ivan Triana [Colombie]

Source :

JCO global oncology [ 2687-8941 ] ; 2020.

RBID : pubmed:32282234

Descripteurs français

KwdFr :
- Chine, Humains, Infections à coronavirus, Pandémies, Pneumopathie virale, Virus du SRAS.
MESH :
- Chine, Humains, Infections à coronavirus, Pandémies, Pneumopathie virale, Virus du SRAS.
Wicri :
- geographic : République populaire de Chine.

English descriptors

KwdEn :
- Betacoronavirus, China, Coronavirus Infections, Humans, Pandemics, Pneumonia, Viral, SARS Virus.
MESH :
- geographic : China.
- Betacoronavirus, Coronavirus Infections, Humans, Pandemics, Pneumonia, Viral, SARS Virus.

DOI: 10.1200/GO.20.00093
PubMed: 32282234

Affiliations:

Colombie

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version.</title>
<author><name sortKey="Pino, Luis" sort="Pino, Luis" uniqKey="Pino L" first="Luis" last="Pino">Luis Pino</name>
<affiliation wicri:level="1"><nlm:affiliation>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá</wicri:regionArea>
<wicri:noRegion>Bogotá</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perez, Carlos" sort="Perez, Carlos" uniqKey="Perez C" first="Carlos" last="Perez">Carlos Perez</name>
<affiliation wicri:level="1"><nlm:affiliation>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá</wicri:regionArea>
<wicri:noRegion>Bogotá</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cardona, Andres" sort="Cardona, Andres" uniqKey="Cardona A" first="Andres" last="Cardona">Andres Cardona</name>
<affiliation wicri:level="1"><nlm:affiliation>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá</wicri:regionArea>
<wicri:noRegion>Bogotá</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Triana, Ivan" sort="Triana, Ivan" uniqKey="Triana I" first="Ivan" last="Triana">Ivan Triana</name>
<affiliation wicri:level="1"><nlm:affiliation>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá</wicri:regionArea>
<wicri:noRegion>Bogotá</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32282234</idno>
<idno type="pmid">32282234</idno>
<idno type="doi">10.1200/GO.20.00093</idno>
<idno type="wicri:Area/PubMed/Corpus">000201</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000201</idno>
<idno type="wicri:Area/PubMed/Curation">000201</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000201</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000694</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000694</idno>
<idno type="wicri:Area/Ncbi/Merge">003919</idno>
<idno type="wicri:Area/Ncbi/Curation">003919</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003919</idno>
<idno type="wicri:Area/Main/Merge">000877</idno>
<idno type="wicri:Area/Main/Curation">000877</idno>
<idno type="wicri:Area/Main/Exploration">000877</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version.</title>
<author><name sortKey="Pino, Luis" sort="Pino, Luis" uniqKey="Pino L" first="Luis" last="Pino">Luis Pino</name>
<affiliation wicri:level="1"><nlm:affiliation>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá</wicri:regionArea>
<wicri:noRegion>Bogotá</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perez, Carlos" sort="Perez, Carlos" uniqKey="Perez C" first="Carlos" last="Perez">Carlos Perez</name>
<affiliation wicri:level="1"><nlm:affiliation>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá</wicri:regionArea>
<wicri:noRegion>Bogotá</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cardona, Andres" sort="Cardona, Andres" uniqKey="Cardona A" first="Andres" last="Cardona">Andres Cardona</name>
<affiliation wicri:level="1"><nlm:affiliation>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá</wicri:regionArea>
<wicri:noRegion>Bogotá</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Triana, Ivan" sort="Triana, Ivan" uniqKey="Triana I" first="Ivan" last="Triana">Ivan Triana</name>
<affiliation wicri:level="1"><nlm:affiliation>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia.</nlm:affiliation>
<country xml:lang="fr">Colombie</country>
<wicri:regionArea>Luis Pino, MD, MSc, MBA, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá, Colombia; Carlos Perez, MD, Clínica de Marly, University Hospital La Samaritana, Bogotá, Colombia; Andres Cardona, MD, PhD, MSc, Clínica del Country, Bogotá, Colombia; and Ivan Triana, MD, Carlos Ardila Lülle Cancer Institute, Fundación Santafe, Bogotá</wicri:regionArea>
<wicri:noRegion>Bogotá</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">JCO global oncology</title>
<idno type="eISSN">2687-8941</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus</term>
<term>China</term>
<term>Coronavirus Infections</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Chine</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>Coronavirus Infections</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Chine</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Colombie</li>
</country>
</list>
<tree><country name="Colombie"><noRegion><name sortKey="Pino, Luis" sort="Pino, Luis" uniqKey="Pino L" first="Luis" last="Pino">Luis Pino</name>
</noRegion>
<name sortKey="Cardona, Andres" sort="Cardona, Andres" uniqKey="Cardona A" first="Andres" last="Cardona">Andres Cardona</name>
<name sortKey="Perez, Carlos" sort="Perez, Carlos" uniqKey="Perez C" first="Carlos" last="Perez">Carlos Perez</name>
<name sortKey="Triana, Ivan" sort="Triana, Ivan" uniqKey="Triana I" first="Ivan" last="Triana">Ivan Triana</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000877 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000877 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32282234
   |texte=   Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32282234" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

Serveur d'exploration SRAS

Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version.

Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.